Bristol-Myers Squibb | BMY - Vergi Öncesi Kar





Vergi Öncesi Kar Değişiklik Tarih
AbbVie USD 7.87B 253M 2026-09
Abbott USD 2.92B 535M 2026-09
ALKERMES USD -1.88M 60.05M 2026-06
Amgen USD 4.19B 1.42B 2026-09
AstraZeneca USD 5.49B 684.4M 2026-09
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Coherus Biosciences USD -46.35M 90.86M 2025-12
Drreddys Laboratories INR 12.28B 10.28B 2026-09
Eli Lilly USD 8.79B 457M 2026-09
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
J&J USD 7.67B 988M 2026-09
Medtronic USD 2.26B 190M 2026-06
Merck USD -683M 2.85B 2026-06
Novartis USD 4.27B 430M 2026-06
Novo Nordisk DKK 33.8B 3.23B 2025-06
Perrigo USD 105.4M 513.9M 2026-06
Pfizer USD 3.38B 4.04B 2026-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 64.77M 2.96M 2026-03
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 5.28B 4.44B 2026-09
Sanofi EUR 6.07B 5.23B 2026-09
United Therapeutics USD 372.7M 54.4M 2026-06
Zoetis USD 758M 3M 2026-03